163 related articles for article (PubMed ID: 9663892)
1. Folic acid treatment of hyperhomocysteinemia in peritoneal dialysis patients: no change in endothelial function after long-term therapy.
van Guldener C; Janssen MJ; Lambert J; ter Wee PM; Donker AJ; Stehouwer CD
Perit Dial Int; 1998; 18(3):282-9. PubMed ID: 9663892
[TBL] [Abstract][Full Text] [Related]
2. Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients.
van Guldener C; Janssen MJ; de Meer K; Donker AJ; Stehouwer CD
J Intern Med; 1999 Feb; 245(2):175-83. PubMed ID: 10081520
[TBL] [Abstract][Full Text] [Related]
3. No change in impaired endothelial function after long-term folic acid therapy of hyperhomocysteinaemia in haemodialysis patients.
van Guldener C; Janssen MJ; Lambert J; ter Wee PM; Jakobs C; Donker AJ; Stehouwer CD
Nephrol Dial Transplant; 1998 Jan; 13(1):106-12. PubMed ID: 9481724
[TBL] [Abstract][Full Text] [Related]
4. Does folic acid decrease plasma homocysteine and improve endothelial function in patients with predialysis renal failure?
Thambyrajah J; Landray MJ; McGlynn FJ; Jones HJ; Wheeler DC; Townend JN
Circulation; 2000 Aug; 102(8):871-5. PubMed ID: 10952955
[TBL] [Abstract][Full Text] [Related]
5. Treatment of hyperhomocysteinemia in children on dialysis by folic acid.
Schröder CH; de Boer AW; Giesen AM; Monnens LA; Blom H
Pediatr Nephrol; 1999 Sep; 13(7):583-5. PubMed ID: 10460506
[TBL] [Abstract][Full Text] [Related]
6. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
7. Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering.
Doshi SN; McDowell IF; Moat SJ; Payne N; Durrant HJ; Lewis MJ; Goodfellow J
Circulation; 2002 Jan; 105(1):22-6. PubMed ID: 11772871
[TBL] [Abstract][Full Text] [Related]
8. Folic acid enhances endothelial function and reduces blood pressure in smokers: a randomized controlled trial.
Mangoni AA; Sherwood RA; Swift CG; Jackson SH
J Intern Med; 2002 Dec; 252(6):497-503. PubMed ID: 12472909
[TBL] [Abstract][Full Text] [Related]
9. Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal disease.
Dierkes J; Domröse U; Ambrosch A; Bosselmann HP; Neumann KH; Luley C
Clin Nephrol; 1999 Feb; 51(2):108-15. PubMed ID: 10069646
[TBL] [Abstract][Full Text] [Related]
10. Dimethylglycine accumulates in uremia and predicts elevated plasma homocysteine concentrations.
McGregor DO; Dellow WJ; Lever M; George PM; Robson RA; Chambers ST
Kidney Int; 2001 Jun; 59(6):2267-72. PubMed ID: 11380830
[TBL] [Abstract][Full Text] [Related]
11. Response of homocysteine, cystathionine, and methylmalonic acid to vitamin treatment in dialysis patients.
Obeid R; Kuhlmann MK; Köhler H; Herrmann W
Clin Chem; 2005 Jan; 51(1):196-201. PubMed ID: 15528294
[TBL] [Abstract][Full Text] [Related]
12. Betaine supplementation decreases post-methionine hyperhomocysteinemia in chronic renal failure.
McGregor DO; Dellow WJ; Robson RA; Lever M; George PM; Chambers ST
Kidney Int; 2002 Mar; 61(3):1040-6. PubMed ID: 11849459
[TBL] [Abstract][Full Text] [Related]
13. Short term betaine therapy fails to lower elevated fasting total plasma homocysteine concentrations in hemodialysis patients maintained on chronic folic acid supplementation.
Bostom AG; Shemin D; Nadeau MR; Shih V; Stabler SP; Allen RH; Selhub J
Atherosclerosis; 1995 Feb; 113(1):129-32. PubMed ID: 7755649
[No Abstract] [Full Text] [Related]
14. Different doses of oral folic acid for homocysteine-lowering therapy in patients on hemodialysis: a randomized controlled trial.
Ossareh S; Shayan-Moghaddam H; Salimi A; Asgari M; Farrokhi F
Iran J Kidney Dis; 2009 Oct; 3(4):227-33. PubMed ID: 19841527
[TBL] [Abstract][Full Text] [Related]
15. [Effects of folic acid supplementation on hyperhomocysteinemia in CAPD patients: effects on unsaturated fatty acids].
Hirose S; Kim S; Matsuda A; Itakura Y; Matsumura O; Tamura H; Nagasawa R; Mitarai T; Isoda K
Nihon Jinzo Gakkai Shi; 1998 Jan; 40(1):8-16. PubMed ID: 9513377
[TBL] [Abstract][Full Text] [Related]
16. Carotid artery stiffness in patients with end-stage renal disease: no effect of long-term homocysteine-lowering therapy.
van Guldener C; Lambert J; ter Wee PM; Donker AJ; Stehouwer CD
Clin Nephrol; 2000 Jan; 53(1):33-41. PubMed ID: 10661480
[TBL] [Abstract][Full Text] [Related]
17. A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease.
Thambyrajah J; Landray MJ; Jones HJ; McGlynn FJ; Wheeler DC; Townend JN
J Am Coll Cardiol; 2001 Jun; 37(7):1858-63. PubMed ID: 11401123
[TBL] [Abstract][Full Text] [Related]
18. Difference in the homocysteine-lowering effect of folic acid in haemodialysis patients with and without occlusive vascular disease.
Descombes E; Boulat O; Bersier LF; Fellay G
Nephrol Dial Transplant; 2001 Mar; 16(3):585-9. PubMed ID: 11239036
[TBL] [Abstract][Full Text] [Related]
19. Effects of folic acid and N-acetylcysteine on plasma homocysteine levels and endothelial function in patients with coronary artery disease.
Yilmaz H; Sahin S; Sayar N; Tangurek B; Yilmaz M; Nurkalem Z; Onturk E; Cakmak N; Bolca O
Acta Cardiol; 2007 Dec; 62(6):579-85. PubMed ID: 18214123
[TBL] [Abstract][Full Text] [Related]
20. Treatment with different doses of folic acid in haemodialysis patients: effects on folate distribution and aminothiol concentrations.
Arnadottir M; Gudnason V; Hultberg B
Nephrol Dial Transplant; 2000 Apr; 15(4):524-8. PubMed ID: 10727548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
